Rifaximin+omeprazole+miralax (DrugBank: Omeprazole, Rifaximin)
16 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
6 | パーキンソン病 | 0 |
8 | ハンチントン病 | 0 |
13 | 多発性硬化症/視神経脊髄炎 | 0 |
21 | ミトコンドリア病 | 0 |
46 | 悪性関節リウマチ | 0 |
51 | 全身性強皮症 | 0 |
85 | 特発性間質性肺炎 | 0 |
96 | クローン病 | 1 |
97 | 潰瘍性大腸炎 | 0 |
98 | 好酸球性消化管疾患 | 0 |
225 | 先天性腎性尿崩症 | 0 |
271 | 強直性脊椎炎 | 0 |
282 | 先天性赤血球形成異常性貧血 | 0 |
294 | 先天性横隔膜ヘルニア | 0 |
298 | 遺伝性膵炎 | 0 |
299 | 嚢胞性線維症 | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02272868 (ClinicalTrials.gov) | January 2015 | 16/10/2014 | Fecal Microbial Transplant in Pediatric Crohn's Disease | Fecal Microbial Transplant in Pediatric Crohn's Disease: A Double Blind Placebo Control Study | Crohn's Disease | Biological: Fecal Microbial transplant;Drug: Normal Saline;Drug: rifaximin+omeprazole+miralax | Seattle Children's Hospital | NULL | Completed | 12 Years | 21 Years | All | 7 | Phase 1;Phase 2 | United States |